Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia

BMC Public Health

Dominique A Cadilhac⁴  Stephen Colagiuri¹  Alison Hicks²  Tara Purvis³  Nadine E Andrew³  Roslyn Johnson²  Monique F Kilkenny⁴ 

[1] Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, The University of Sydney, Sydney 2006, NSW, Australia;National Stroke Foundation, Melbourne 3000, Vic, Australia;Stroke and Ageing Research School of Clinical Sciences at Monash Health, Monash University, Level 1/43-51 Kanooka Grove, Clayton, 3168 Melbourne, VIC, Australia;The University of Melbourne, Melbourne 3010, Vic, Australia

关键词: Random blood glucose testing;    AUSDRISK;    Health promotion;    Risk factors;    Health care;    Prevention;    Cerebrovascular disease;    Diabetes;    Hypertension;   

Others  :  1122884
DOI  :  10.1186/1471-2458-14-1227

 received in 2014-05-21, accepted in 2014-11-17,  发布年份 2014

【 摘 要 】

Background

Since 2007, the Australian Know your numbers (KYN) program has been used in community settings to raise awareness about blood pressure and stroke. In 2011, the program was modified to include assessment for type 2 diabetes risk. However, it is unclear which approach for assessing diabetes risk in pharmacies is best. We compared two methods: random (non-fasting) blood glucose testing (RBGT); and the Australian type 2 diabetes risk assessment tool (AUSDRISK); according to 1) identification of ‘high risk’ participants including head-to-head sensitivity and specificity; 2) number of referrals to doctors; and 3) feasibility of implementation.

Methods

117 Queensland pharmacies voluntarily participated and were randomly allocated to RBGT and AUSDRISK or AUSDRISK only. Although discouraged, pharmacies were able to change allocated group prior to commencement. AUSDRISK is a validated self-administered questionnaire used to calculate a score that determines the 5-year risk of developing type 2 diabetes. AUSDRISK (score 12+) or RBGT (≥5.6 mmol/I) indicates a high potential risk of diabetes. Median linear regression was used to compare the two measures. Staff from 68 pharmacies also participated in a semi-structured interview during a site visit to provide feedback.

Results

Data were submitted for 5,483 KYN participants (60% female, 66% aged >55 years, 10% history of diabetes). Approximately half of the participants without existing diabetes were identified as ‘high risk’ based on either RBGT or AUSDRISK score. Among participants who undertook both measures, 32% recorded a high RBGT and high AUSDRISK. There was a significant association between RBGT and AUSDRISK scores. For every one point increase in AUSDRISK score there was a half point increase in RBGT levels (coefficient 0.55, 95% CI: 0.28, 0.83). Pharmacy staff reported that AUSDRISK was a simple, low cost and efficient method of assessing diabetes risk compared with RBGT, e.g. since management of sharps is not an issue.

Conclusions

In a large, community-based sample of Australians about half of the participants without diabetes were at ‘high risk ‘of developing diabetes based on either AUSDRISK or RBGT results. AUSDRISK was considered to be an acceptable method for assessing the risk of diabetes using opportunistic health checks in community pharmacies.

【 授权许可】

   
2014 Kilkenny et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Guariguata L: Contribute data to the 6th edition of the IDF diabetes atlas. Diabetes Res Clin Pract 2013, 100(2):280-281.
• [2]Begg SJ, Vos ET, Barker B, Stevenson CE, Stanley L, Lopez AD: The Burden of Disease and Injury in Australia 2003. PHE 82. Canberra: Australian Institute of Health and Welfare; 2007.
• [3]Alliance NVDP: Guidelines for the management of absolute cardiovascular risk. Melbourne: National Heart Foundation of Australia; 2012.
• [4]AIHW: Stroke and its Management in Australia: An Update. 37th edition. Canberra: AIHW; 2013.
• [5]Ebrahim S, Harwood R: Stroke: Epidemiology, Evidence, and Clinical Practice. 2nd edition. Oxford: Oxford University Press; 1999.
• [6]Slark J, Bentley P, Majeed A, Sharma P: Awareness of stroke symptomatology and cardiovascular risk factors amongst stroke survivors. J Stroke Cerebrovasc Dis 2012, 21(5):358-362.
• [7]Saaristo T, Peltonen M, Keinanen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L, Oksa H, Korpi-Hyovalti E, Tuomilehto J, Group F-DDS: National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health 2007, 66(2):101-112.
• [8]Ali MK, Echouffo-Tcheugui J, Williamson DF: How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood) 2012, 31(1):67-75.
• [9]Hernan A, Philpot B, Janus ED, Dunbar JA: Recruitment into diabetes prevention programs: what is the impact of errors in self-reported measures of obesity? BMC Public Health 2012, 12:510. BioMed Central Full Text
• [10]Davis-Lameloise N, Hernan A, Janus ED, Stewart E, Carter R, Bennett CM, O'Reilly S, Philpot B, Vartiainen E, Dunbar JA, Melbourne Diabetes Prevention Study Research: The Melbourne diabetes prevention study (MDPS): study protocol for a randomized controlled trial. Trials 2013, 14:31. BioMed Central Full Text
• [11]Leach MJ, Segal L, Esterman A, Armour C, McDermott R, Fountaine T: The diabetes care project: an Australian multicentre, cluster randomised controlled trial [study protocol]. BMC Public Health 2013, 13(1):1212. BioMed Central Full Text
• [12]Campbell T, Dunt D, Fitzgerald JL, Gordon I: The impact of patient narratives on self-efficacy and self-care in Australians with type 2 diabetes: stage 1 results of a randomized trial. Health Promot Int 2013., 28[Epub ahead of print]
• [13]Walker C, Hernan A, Reddy P, Dunbar JA: Sustaining modified behaviours learnt in a diabetes prevention program in regional Australia: the role of social context. BMC Health Serv Res 2012, 12:460. BioMed Central Full Text
• [14]Reddy P, Hernan AL, Vanderwood KK, Arave D, Niebylski ML, Harwell TS, Dunbar JA: Implementation of diabetes prevention programs in rural areas: Montana and south-eastern Australia compared. Aust J Rural health 2011, 19(3):125-134.
• [15]Chan YK, Stewart S, Calderone A, Scuffham P, Goldstein S, Carrington MJ, Young @ Heart I: Exploring the potential to remain "Young @ Heart": initial findings of a multi-centre, randomised study of nurse-led, home-based intervention in a hybrid health care system. Int J Cardiol 2012, 154(1):52-58.
• [16]Krass I, Mitchell B, Clarke P, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J, Armour C: Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract 2007, 75(3):339-347.
• [17]Dhippayom T, Chaiyakunapruk N, Krass I: How diabetes risk assessment tools are implemented in practice: A systematic review. Diabetes Res Clin Pract 2014, 104(3):329-342.
• [18]Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, Mitchell P, Phillips PJ, Shaw JE: AUSDRISK: an Australian type 2 diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 2010, 192(4):197-202.
• [19]Cadilhac DA, Kilkenny MF, Johnson R, Wilkinson B, Amatya B, Lalor E: The know your numbers (KYN) program 2008 to 2010: impact on knowledge and health promotion behavior among participants. Int J Stroke 2013., 12doi:10.1111/ijs.12018
• [20]Kilkenny MF, Johnson RR, Cadilhac DA, National Stroke F: Feasibility of a pilot programme to increase awareness of blood pressure as an important risk factor for stroke in Australia. Int J Stroke 2010, 5(5):344-350.
• [21]Australian Institute of Health and Welfare: Australia's Health. Canberra: AIHW; 2012.
• [22]Foundation H: Guide to management of hypertension 2008: Assessing and managing raised blood pressure in adults. In Edited by Foundation H; Updated. 2010.
• [23]Trotter R: Qualitative research sample design and sample size: Resolving and unresolved issues and inferential imperatives. Prev Med 2012, 55:398-400.
• [24]Tonkin AM, Boyden AN, Colagiuri S: Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general population. Med J Aust 2009, 191(6):300-302.
• [25]Cugati S, Wang JJ, Rochtchina E, Mitchell P: Ten-year incidence of diabetes in older Australians: the blue mountains Eye study. Med J Aust 2007, 186(3):131-135.
• [26]Grant JF, Chittleborough CR, Taylor AW, Dal Grande E, Wilson DH, Phillips PJ, Adams RJ, Cheek J, Price K, Gill T, Ruffin RE, North West Adelaide Health Study, Team: The north west Adelaide health study: detailed methods and baseline segmentation of a cohort for selected chronic diseases. Epidemiol Perspect Innov EP + I 2006, 3:4. BioMed Central Full Text
• [27]Pasco JA, Kotowicz MA, Henry MJ, Nicholson GC: Evaluating AUSDRISK for predicting incident diabetes in an independent sample of women. Med J Aust 2010, 193(6):374.
• [28]Wong KC, Brown AM, Li SC: AUSDRISK - application in general practice. Aust Fam Physician 2011, 40(7):524-526.
• [29]Dunbar JA, Jayawardena A, Johnson G, Roger K, Timoshanko A, Versace VL, Shill J, Philpot B, Vartiainen E, Laatikainen T, Best JD, Janus ED: Scaling up diabetes prevention in victoria, australia: policy development, implementation, and evaluation. Diabetes Care 2014, 37(4):934-942.